Doximity Comprehensive Income 2020-2024 | DOCS
- Doximity comprehensive income for the quarter ending December 31, 2024 was $0.001B, a 121.81% decline year-over-year.
- Doximity comprehensive income for 2024 was $-0.003B, a 81.08% decline from 2023.
- Doximity comprehensive income for 2023 was $-0.014B, a 7.92% decline from 2022.
- Doximity comprehensive income for 2022 was $-0.015B, a 72728.57% increase from 2021.
Doximity Annual Comprehensive Income (Millions of US $) |
|
---|---|
2024 | $-3 |
2023 | $-14 |
2022 | $-15 |
2021 | $0 |
2020 | $0 |
2019 | $0 |
Doximity Quarterly Comprehensive Income (Millions of US $) |
|
---|---|
2024-12-31 | $1 |
2024-09-30 | $3 |
2024-06-30 | $-1 |
2024-03-31 | $-3 |
2023-12-31 | $-5 |
2023-09-30 | $-9 |
2023-06-30 | $-12 |
2023-03-31 | $-14 |
2022-12-31 | $-19 |
2022-09-30 | $-22 |
2022-06-30 | $-18 |
2022-03-31 | $-15 |
2021-12-31 | $-4 |
2021-09-30 | $-1 |
2021-06-30 | $0 |
2021-03-31 | $0 |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $11.396B | $0.475B |
Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.728B | 26.96 |
Elevance Health (ELV) | United States | $94.145B | 12.15 |
CVS Health (CVS) | United States | $81.986B | 10.19 |
Cencora (COR) | United States | $53.983B | 18.77 |
Natera (NTRA) | United States | $21.477B | 0.00 |
DiDi Global (DIDIY) | China | $21.462B | 32.57 |
BioMerieux (BMXMF) | France | $15.263B | 0.00 |
Solventum (SOLV) | United States | $12.941B | 13.70 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
Revvity (RVTY) | United States | $11.610B | 19.98 |
ICON (ICLR) | Ireland | $11.324B | 10.53 |
CochLear (CHEOY) | Australia | $11.195B | 0.00 |
Viatris (VTRS) | United States | $10.516B | 3.61 |
Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
Avantor (AVTR) | United States | $8.859B | 12.87 |
HealthEquity (HQY) | United States | $8.361B | 41.13 |
Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
Sotera Health (SHC) | United States | $3.832B | 21.77 |
Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
Concentras Parent (CON) | United States | $2.771B | 16.01 |
Organon (OGN) | United States | $2.264B | 2.41 |
Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
Premier (PINC) | United States | $2.101B | 14.38 |
Progyny (PGNY) | United States | $1.886B | 41.51 |
PACS (PACS) | United States | $1.698B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
Agilon Health (AGL) | United States | $1.229B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.911B | 14.23 |
AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
Embecta (EMBC) | United States | $0.725B | 4.89 |
QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
Nutex Health (NUTX) | United States | $0.689B | 13.50 |
Enhabit (EHAB) | United States | $0.530B | 43.58 |
InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
LifeMD (LFMD) | United States | $0.389B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
SBC Medicals (SBC) | United States | $0.359B | 0.00 |
Beauty Health (SKIN) | United States | $0.220B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
Oncology Institute (TOI) | United States | $0.193B | 0.00 |
DocGo (DCGO) | United States | $0.147B | 24.08 |
Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
So-Young (SY) | China | $0.087B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
KindlyMD (KDLY) | United States | $0.082B | 0.00 |
OncoCyte (OCX) | United States | $0.080B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
Biodesix (BDSX) | United States | $0.053B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
ModivCare (MODV) | United States | $0.018B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |